Image

Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

Therapeutic patient education (TPE) is a key element in the management of people living with type 2 diabetes.

The benefit of therapeutic education (TPE) has been clearly established on glycaemic control.

Continuous interstitial glucose monitoring (CGM) can be considered as a TPE tool for people living with diabetes. A direct reading of the effects of diet and physical activity on glycaemic levels could have an impact on the initiation and maintenance of therapeutic lifestyle modifications.

The investigators therefore propose a prospective randomised study in 2 arms :

  • a group of people living with diabetes receiving standard TPE vs
  • a group of people living with diabetes receiving standard TPE + FSL 28 days Ourmain objective is to determine the benefit of CGM on HbA1c at 3 months between 2 arms

Description

Main objective to the investigators is to determine the benefit of continuous interstitial glucose monitoring (by fresstyle 2) for 28 days coupled with standard TPE (Patient Therapeutic Education) vs standard TPE alone in newly diagnosed type 2 diabetics on HbA1c at 3 months.

The secondary objectives are to evaluate the effect of the TPE coupled with FSL vs TPE alone on :

  • HbA1c at 6 months (assessment of persistence or not of a remote effect)
  • weight change at 3 and 6 months
  • other cardiovascular risk factors : variation in blood pressure, lipid profil at 3 and 6 months
  • eating behaviour/ eating habits at 3 and 6 months
  • treatment satisfaction, anxiety and quality of life scores

Eligibility

Inclusion Criteria:

  • recently diagnosed diabete mellitus (<1 an) treated by non medical therapeutics and/or metformine
  • > 18 years old
  • initial glycated hemoglobin between 7 and 8.5%

Exclusion Criteria:

  • Person whose physical and/or psychological health is severely impaired
  • Person deprived of his rights, person under guardianship or curatorship
  • Person deprived of liberty (by judicial or administrative decision)
  • Person who does not speak the French language
  • Absence of affiliation to/Not beneficiary of a Social Security scheme
  • Absence of written informed consent to participate in the study
  • Unable to understand the nature, purpose and methodology of the study
  • Bariatric surgery planned within 6 months of inclusion

Study details

Endocrinology, Type 2 Diabetes

NCT05676593

University Hospital, Montpellier

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.